{"schema_version":"secwatch.filing_event.v1","accession":"0001787306-21-000013","form_type":"8-K","ticker":"ARQT","cik":"0001787306","company_name":"Arcutis Biotherapeutics, Inc.","filed_at":"2021-09-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.670089+00:00","generated_at":"2026-06-29T05:35:19.409028+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Arcutis appoints Keith Leonard as Class I director; Ricky Sun resigns without disagreement","bullets":["Keith R. Leonard Jr. appointed Class I director, term expiring at 2024 annual meeting, effective Sept 2.","Ricky Sun resigned from Board effective Sept 2; no disagreement with company operations or policies.","Leonard joins Compensation Committee; receives 32,907-share stock option (3-year annual vest).","Annual cash retainer of $40,000 for Board service plus $7,500 for Compensation Committee membership.","Leonard to enter standard indemnification agreement with Arcutis."],"urls":{"canonical":"https://secwatch.observer/filing/0001787306-21-000013","json":"https://secwatch.observer/filing/0001787306-21-000013.json","markdown":"https://secwatch.observer/filing/0001787306-21-000013.md","text":"https://secwatch.observer/filing/0001787306-21-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787306/000178730621000013/0001787306-21-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787306/000178730621000013/arqt-20210903.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T05:35:19.409028+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9eba4356ab","claim":"Keith R. Leonard Jr. was appointed as Class I director at Arcutis Biotherapeutics, Inc..","evidence_excerpt":"On September 2, 2021, the Board of Directors (the “Board”) of Arcutis Biotherapeutics, Inc. (the “Company” or “Arcutis”) appointed Keith R. Leonard Jr. as a Class I director with a term expiring at the Company’s 2024 Annual Meeting of Stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730621000013/0001787306-21-000013-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I director"}],"fact_type":"executive_change"},{"claim_id":"cb431666fd","claim":"Ricky Sun resigned as Director at Arcutis Biotherapeutics, Inc..","evidence_excerpt":"Mr. Leonard fills the vacancy created by the resignation of Ricky Sun, Ph.D. who resigned from the Board effective September 2, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730621000013/0001787306-21-000013-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}